Related by context. All words. (Click for frequent words.) 70 RADIANT 68 AVADO 67 ATTRACT 67 TRANSFORMS 66 multicentre randomized 66 BOLDER 66 CLINICAL TRIAL 66 CONQUER 66 PHASE III 66 randomized controlled Phase 65 ASTEROID 65 PRECISE 65 placebo controlled Phase 65 Randomized Phase 65 TMC# C# 65 Initiated Phase 64 Initiate Phase 64 PEDESTAL 64 SEQUEL 63 ILLUMINATE 63 randomized Phase III 63 randomized multicenter 63 PHASE II 63 ASSIGNMENT OF ERROR 63 TRIAL OF 63 SORT OUT 63 BLOSSOM 63 LUX Lung 63 multicenter Phase 63 EMILIA 62 PREVAIL 62 PRE SURGE 62 FREEDOMS 62 label multicenter Phase 62 IN PATIENTS WITH 62 RESIST 62 DIAGNOSTIC 62 TO PREDICT 62 oral ridaforolimus 62 SANTE 62 CONFIRM 62 STENT 61 phase IIIb 61 GOUT 61 STELLAR 61 STUDY OF 61 BCIRG 61 WINDOW OF 61 HALTS 61 CABERNET 61 Pivotal Phase 61 TREATMENT AND 61 Study Evaluating 61 TEST OF 61 multicenter randomized controlled 61 TROPIC 61 MATCHED 61 THE STUDY 61 SPIRIT FIRST 61 UNLOAD 61 Randomized Phase II 61 SERENE 61 phase IIb 61 REVIVE 61 ALLEGRO 61 CORPORATION ANNOUNCES 60 FOR TREATMENT 60 PROTEGE 60 NO MORE THAN 60 assessing T DM1 60 multicenter randomized placebo controlled 60 PET FROM 60 PROCEED 60 TO AVOID PREGNANCY WHILE 60 RECOMMENDED FOR 60 FDA APPROVES 60 ALLEVIATE 60 CLINICAL TRIALS 60 GAUDIO 60 COVERAGE FOR 60 TREATMENT OF 60 UPGRADE TO 60 EXTENDING THE 60 Prostate AdenoCarcinoma Treatment 60 DRILL HOLE 60 AN OPTION FOR 60 evaluating Vectibix 60 multicenter phase 60 POST CONVICTION RELIEF 60 pan histone deacetylase 60 PEG IFN 60 DURATION 60 CABANA 60 THERAPEUTICS 60 BREEDERS CROWN 60 Phase IIIb 60 PUBLICATION OF 60 CUPID 60 ON THE FOLLOWING 60 BOLDER II 60 MOTIVATE 60 PERSEUS 60 Phase Ib clinical 60 OF PROXIES FOR 60 PATENT 60 CAMELOT 60 ACCLAIM 60 LEARNING ABOUT 59 DELIVERING THE 59 THERAPY AND 59 MOTION FOR 59 registrational trial 59 GUINEAS 59 DOUBLE FOR 59 APPROXIMATE 59 Phase III randomized 59 STUDY RESULTS 59 IDENTITY OF 59 BRIM2 59 prospective multicenter 59 MORTALITY 59 NECKLACE 59 Prospective Randomized 59 dose escalation clinical 59 THIS TORNADO 59 IN COMBINATION WITH 59 SHUN 59 Sorafenib HCC Assessment 59 CELLO 59 CLOSE TO THE 59 FOR SEX 59 multicenter randomized double 59 CARDIOVASCULAR 59 registrational Phase 59 COUNSEL OF 59 RESPONSES TO 59 HUMIDITY WILL 59 COMPANION 59 THE ORLANDO FLA. 59 REVENGE FOR 59 AMERICA 'S FUTURE 59 phase IIb study 59 EXPECTING TOUGH 59 phase IIb clinical 59 PAGES OF 59 II Clinical Trial 59 WE WILL CONTINUE TO 59 ARBITER 59 TOP SEEDS 59 metastatic hormone refractory 59 BELIEVES IN 59 ENTRANCE 59 CHALLENGE SERIES 59 EMPHASIS ON 59 dose escalation Phase 59 THYROID 59 Drug Eluting Stent System 59 CANCER TREATMENT 59 MEMORY OF 59 ARDIS 59 Phase III randomized controlled 59 RECEIPT OF 59 GLORY FOR 59 MUSTACHE 58 AWAY DAY 58 NEW WAY TO 58 ongoing Phase 1b 58 FEMALES SHOULD BE ADVISED 58 ERRED WHEN IT 58 DA VINCI 58 WHATS THE 58 ZACTIMA 58 FILLY 58 TRAINING FOR 58 ROADMAP 58 PRIZE FOR 58 CUSTOM 58 TO COMPETE 58 FREE PILLS 58 DISORDERS 58 CELEBRATION OF THE 58 DRAW FOR 58 ExTRACT TIMI 58 satraplatin Phase 58 TO PATIENTS 58 Phase Ib study 58 MOMENTS IN 58 ID NCT# 58 phase IIa 58 BATTLING FOR 58 SAFETY OF 58 R roscovitine CDK cyclin 58 Multicenter 58 TLK# 58 SECOND ROUND OF 58 ERRED IN 58 FOR EACH 58 viral kinetic 58 GULF WAR 58 docetaxel Taxotere R 58 ADDRESS AND 58 ANY CHANGES 58 TO PUBLISH 58 evaluating Actimmune 58 ABSTRACTS 58 Randomized Double Blind 58 GOODBYE TO 58 PRESENTING 58 GRAB YOUR 58 HOLS 58 FILLIES 58 INTEREST OF 58 TEARS FOR 58 treatment naive genotype 58 TALK WITH 58 PRELIM 58 FOR NEXT WEEK 58 ILLNESSES 58 SABCS 58 WE DO NOT NEED 58 CHANCE OF 58 BRIM3 58 Aflibercept 58 COMES WITH 58 COWELL 'S 58 ABLYNX 58 BENEFITS FROM 58 multicenter randomized 58 STATIONARY 58 DEFINE 58 RELIEVED TO 58 placebo controlled randomized 58 controlled multicenter Phase 58 multicenter placebo controlled 58 OVARIAN CANCER 58 RADIATE 58 MINDSET 58 colesevelam HCl 58 virus HCV protease inhibitor 58 multicenter Phase III 58 Randomized Double Blind Placebo 58 mGluR5 negative 58 WAY TO THE 58 CARE HOME 58 label multicenter 58 CHASES 58 REVEAL 58 prospective randomized controlled 58 NEW STADIUM 58 CLIMBS TO 57 WAYS TO 57 HuMax EGFr 57 By JENNIFER LEARN 57 POUNDS OF 57 TO SHINE 57 ROBBIE 'S 57 COSTS TO BE 57 HORIZON 57 TO ORDER 57 WINDS AND 57 Dose Ranging Study 57 STRATEGIC ALLIANCE 57 EVENING WITH 57 MOTION TO 57 RAVEL 57 TRYING TO GET 57 REPORTS THIRD QUARTER 57 MODERNIZATION 57 YOUR CONFIDENCE 57 CHECKER 57 TOP TWO 57 DEFINITIVE 57 CAREFULLY WHEN THEY BECOME 57 TIPSTER 57 DIMINISHED 57 KNOW IF 57 ACCOMPLISH 57 PFO migraine 57 FOR WORLD CUP 57 STAYS AT 57 WHAT PRICE 57 DEFENDANT 'S 57 UNFIT FOR 57 TWIST IN 57 RE LY 57 ONTARGET 57 BUOYED BY 57 NO# [002] 57 ADVISORY AREA 57 MONT BLANC 57 PRE REGISTRATION 57 MAY DIFFER MATERIALLY FROM 57 LOADED WITH 57 HER NEW 57 EXTEND 57 HCV SPRINT 57 IMPACT IMmunotherapy 57 NANOTECH 57 nab paclitaxel 57 randomized Phase 57 ELEVATED 57 comparing alemtuzumab 57 PERSPECTIVES ON 57 FUND INC. 57 REVLIMID lenalidomide 57 TAXUS ATLAS 57 GETS HER 57 PRECiSE 57 ON TWITTER AND 57 IS ASSOCIATED WITH 57 relapsed refractory multiple myeloma 57 ROBBED OF 57 phase Ib 57 IMPACT TRAVEL 57 LOW PRICE GREAT DISCOUNT 57 D#B 57 CANCER PATIENT 57 dose escalation trial 57 PRESENTATION OF 57 TEAR DOWN 57 PARLOUR 57 EURIDIS 57 THERAPY FOR 57 crizotinib PF # 57 TOOL FOR 57 Randomized Double blind 57 WINS STAGE 57 MPH WITH HIGHER 57 LOOK GOOD 57 randomized multicenter trial 57 THE NEED TO 57 Glufosfamide 57 STARSHIP 57 ORAL Sync 57 CLINICAL DATA 57 pertuzumab 57 YEAR FOR 57 MY LITTLE 57 RECOVERY ACT 57 JOY AT 57 dependent kinase inhibitor 57 CONCLUDE 57 TELCYTA 57 LIFT STAY TO PURSUE 57 FOUNDATION 'S 57 MEND CABG 57 PATENT FOR 57 RAINFALL WILL 57 THE VALUE OF 57 CHOSEN TO 57 SLATED 57 randomized Phase IIb 57 STRUGGLE TO 57 ALIBI 57 Phase 2b Study 57 DISAGREE WITH 57 PALETTE 57 HOT TUB 57 ANNOUNCES PARTNERSHIP WITH 57 BECKONS FOR 57 CONVICTION FOR 57 phase Ib clinical 57 DISPLAY OF 57 NOT GETTING 57 HERE THIS WEEKEND 57 SLEIGH 57 HONOURED BY 57 ROUTE TO 57 RESILIENT 57 EDEMA3 57 INDICATE THAT 57 AWARDS FOR 57 RETURNS WITH 57 LONGING FOR 57 QUARTER RESULTS 57 TICKETS TO 57 WITH CONFIDENCE 57 NSABP B 57 Brentuximab Vedotin SGN 57 LOVER 'S 57 Prospective Multicenter 57 SIZE AND 57 PLANS FOR THE 57 BEATER 57 PANTIES 57 DETERMINED TO 57 ANGER AT 57 SENTENCE FOR 57 prospective randomized multicenter 57 TREAT FOR 57 OF DESPAIR 57 APPEAL BOARD 57 TAXUS IV 57 IN KASHMIR 57 CHECKS IN 57 ROCKET AF 57 multicentre randomized double 57 TO IDENTIFY 56 farletuzumab 56 ABCSG 56 CONSCIOUS 56 GUSTO 56 TEST FOR 56 CENTERS FOR DISEASE CONTROL 56 blinded randomized placebo controlled 56 SETTLES FOR 56 Matrix Phase 2b 56 Phase 1b trial 56 ADVANCE PD 56 SECOND QUARTER FISCAL 56 FIBROMYALGIA 56 THE LOWER COURT 56 TO REQUEST 56 CHALLENGE TO 56 FAVOURED 56 UNDERGOES 56 CELEBRATE THE 56 STEP CLOSER TO 56 THEY CAN NOT 56 Pivotal Phase III 56 Phase III placebo controlled 56 POST RE HAB 56 Phase 1b 56 LARGE HAIL 56 OLYMPIC DREAM 56 HUMAN GENOME SCIENCES 56 FALLING TO 56 DEVS 56 INFO ON 56 SPIREITES 56 Intervention Effectiveness 56 START WITH 56 OUR POLITICIANS 56 Topics Covered I. INTRODUCTION 56 AND USE CAUTION 56 CLEANS UP 56 HAS BEEN OBTAINED IMMEDIATELY 56 Phase 2a clinical 56 5q MDS 56 NIGHT FOR 56 YEAR WITH 56 DRIVEN TO 56 TO GET IN 56 APRICOT 56 ERRED BY 56 DURING THAT 56 liposome injection 56 Randomised 56 dexpramipexole 56 CHANCE FOR 56 Ixempra 56 RUNNING OUT OF 56 NEED TO GET 56 INITIATE 56 sunitinib malate 56 Phase 1b dose escalation 56 Phase Ib II 56 THE LATTER 56 PROCESS FOR 56 STAYS IN 56 TROTTERS 56 ODDS ON 56 SONGS OF 56 Pooled Analysis 56 FUTURE EVENTS 56 LOUISIANA AND 56 ALL MY 56 SEEK SHELTER IN 56 CURE FOR 56 WANTS NEW 56 tanespimycin 56 PREPARE FOR 56 THIS ENTIRE ARTICLE 56 DREAMS OF 56 Phase IIb Trial 56 REPORTS RECORD 56 UPPER #S 56 FIRST STEP 56 IS UNFAIR TO BLAME 56 TO COME BACK 56 REVIVE Diabetes 56 refractory chronic lymphocytic 56 HEARINGS ON 56 KYLIE 'S 56 randomized multicentre 56 INFLUENCE ON 56 PROVIDES UPDATE ON 56 masked placebo controlled 56 WHICH CAN 56 LUNG CANCER 56 GET MY 56 BIOSCIENCES 56 cetuximab Erbitux R 56 prospective multicenter randomized 56 candesartan cilexetil 56 Clinical Trial Evaluating 56 NEED MORE 56 PUSH TO 56 SUCCEED trial 56 plus dexamethasone 56 ALL SET FOR 56 Phase #b/#a clinical 56 COPTER 56 SIDE OF THE 56 SERENADE 56 WILL COMBINE 56 FLU VACCINE 56 PROWESS 56 STORACE 56 interferon gamma 1b 56 CONQUERS 56 APPELLANT 'S 56 pivotal Phase III 56 PRIMED FOR 56 RELEASED FROM 56 REALISM 56 histone deacetylase HDAC inhibitor 56 Oral Fingolimod 56 PURSUIT OF 56 ANNOUNCES SECOND 56 ON EBAY 56 metastatic castration resistant 56 AND YOU HAVE 56 MOTIVATOR 56 Controlled Trial 56 EOquin TM 56 REMOVED FROM 56 ADJUSTING TO 56 pan HDAC inhibitor 56 NEEDS HELP 56 Metastatic Melanoma 56 DEADLINE TO 56 Pharmacokinetics PK 56 SUBSCRIBE TO EMAIL ALERTS 56 CLL8 56 WHO TOOK 56 WHAT IS ONE THING 56 PHASE OUT 56 ASCO abstract 56 Stenting Trial 56 multicenter Phase II 56 PROFILES OF 56 SEARCH FOR THE 56 DREAMING OF 56 INFORMATION SYSTEMS 56 UNDER WAY 56 landmark ATHENA 56 INEFFECTIVE ASSISTANCE OF COUNSEL 56 CHECK ON 56 Phase IIIb clinical 56 SURVEY OF 56 ROLL ON 56 FOR CHANGE 56 pharmacokinetics PK 56 SHE DOES NOT 56 SPICE UP 56 PERSON IN 56 THE CONSENT SOLICITATION 56 TOP FOUR 56 LOVES HER 56 #TH BIRTHDAY [001] 56 Phase #/#a 56 TURN DOWN 56 Ceflatonin ® 56 Initiates Phase 56 CHAPTERS 56 THE MADNESS 56 elotuzumab 56 WHAT YOU CAN 56 CALGB 56 ANATOMY OF 56 v. WORKERS COMPENSATION 56 LEGACY OF 56 BE ESPECIALLY CAUTIOUS 56 REVISE 56 TAKEN OFF 56 ARRIVE 56 subanalysis 56 PROGRAM FOR 56 TWO POINT 56 MAGE A3 ASCI 56 'S VICTORY 56 metastatic castrate resistant 56 PHARM 56 BEST ONLINE PHARMACY LOWEST 56 APEX PD 56 MESSAGE FROM 56 MARKER 56 PROSTATE 56 PETITION FOR 56 NATIONAL HEALTH 56 FOR EDUCATION 56 Phase 2a trial 56 REASONS FOR 56 SCORES IN 56 ELEMENT OF 56 KICK IN 56 H#N# VACCINE 55 FAVORABLE 55 SPURRED ON BY 55 JUMPS TO 55 SOCIEDAD 55 OF COUNSEL 55 FOR INTER 55 NAMED IN 55 CLEARED FOR 55 STUDIES AND 55 PERMISSION TO 55 FOR ADDITIONAL 55 pivotal Phase 55 ASSERT 55 PATH TO 55 MYSTICAL 55 Eluting Coronary Stent System 55 PEGINTRON TM 55 SUPPOSED TO BE 55 GOES BACK TO 55 CAPELLA 55 Xeloda ® 55 ENTRY INTO 55 WINGS OF 55 YOUNG WOMEN 55 AND FUTURE 55 Phase 2b study 55 HIS WAY TO 55 double blinded randomized 55 SLAIN IN 55 AIMING TO 55 IMMUNE SYSTEM 55 DESIRE TO 55 LOAD OF 55 TOUCH OF 55 SAYS GOODBYE TO 55 COLLIDE 55 NEW LOOK FOR 55 CLOONEY 'S 55 FEMALE WAS 55 PUSHING FOR 55 XL# SAR# 55 PREGNANT WITH 55 BRACELET 55 randomized controlled multicenter 55 TOPICAL 55 Phase 2b clinical 55 Corey Brotherson 55 DRAWN 55 PRICES GREAT DISCOUNTS 55 pharmacokinetic PK study 55 Phase 2b kidney transplant 55 DOES NOT CONSTITUTE AN 55 YOUR FIRST 55 PICK YOUR 55 Multiple Myeloma MM 55 prospective randomized placebo 55 Meets Primary Endpoint 55 #mg QD [002] 55 FINE AFTER 55 COVERING THE 55 TOUCHED BY 55 CUSTOM II 55 ABUSED ITS DISCRETION 55 PETITION TO 55 HAND TO 55 THEREFORE IT 55 MEDAL 55 neratinib 55 Double Blind Placebo 55 phase 2a 55 SHARPER 55 CAR CHASE 55 HEART FAILURE 55 DEMISE OF 55 DATE SET FOR 55 THIRD TIME 'S 55 Phase Ia 55 STICKS AND 55 'S FINAL 55 SMELLS LIKE 55 adecatumumab MT# 55 metastatic malignant 55 RE LY ® 55 DASISION 55 AND BURN 55 Prospective Randomized Trial 55 Safinamide 55 Tanespimycin 55 MCNAIR 55 * TIMING PERIODS OF 55 HIGHS IN THE 55 CARRA 55 GEARING UP FOR 55 STAYS ON 55 THE ALL STAR 55 BREAK INTO 55 RU EEU EUROPE ASIA 55 BALKAN 55 JUST GIVE 55 INITIATES 55 SHORT TRACK 55 AL SALEH 55 TARGET OF 55 TO SHARE 55 fosbretabulin 55 GO FORWARD 55 JOURNAL OF 55 WHO KILLED 55 LITTLE ONES 55 SCHEME FOR 55 Multiple Ascending Dose 55 GetGoal Phase III 55 multicenter randomized Phase 55 Phase 1b clinical 55 WORRIES FOR 55 NEVO 55 OUR NATION 55 PAYOUTS 55 Complicated Skin 55 PHOSPHATE 55 PRESENTED AT 55 SHOULD THEY 55 docetaxel chemotherapy 55 SERVING UP 55 budesonide MMX 55 THINK ABOUT THE 55 IS REQUIRED 55 FUN FOR 55 SEVEN DAY 55 WEARS 55 OFF YOUR 55 relapsing multiple sclerosis 55 THE SONGS OF 55 ACCORDINGLY 55 INCURRED 55 FOLOTYN ® 55 THE QUEST FOR 55 YOUR MIND 55 GIVE HER 55 THE TOUGHEST 55 PRECEDENT 55 PAN AMERICAN 55 CHEAP ONLINE PHARMACY LOW 55 APTIVUS 55 PICKED TO 55 GATEWAY TO 55 Phase 2b 55 WILL LINGER 55 THE WARNING AREA 55 KNOWS WHAT 55 CARILLON 55 GAUNTLET 55 SEEN THIS 55 Elagolix 55 ORACLE MS 55 randomized controlled clinical 55 GRAPHIC NOVEL 55 Wintergreen Resort STAY 55 BIBW 55 COLLABORATION WITH 55 OUTCOMES 55 Phase 1a clinical 55 WEIGHT OF 55 PRELUDE 55 DANGER TO 55 READY FOR THE 55 'S BABY 55 phase IIa clinical 55 CANCER RESEARCH 55 ONLINE PHARMACY BEST PRICE 55 CROWNED 55 LAST FOUR 55 STEP FORWARD 55 ADDS TO 55 APPRAISE 55 Randomized Phase III 55 LIGHTLY 55 NEEDLE 55 TRIUMPH 55 HURRICANE CONDITIONS ARE EXPECTED 55 ALN VSP Phase 55 CRIMINAL AND 55 SLEET OR ICE ACCUMULATIONS 55 dasatinib Sprycel ® 55 INSPIRED BY 55 evaluating T DM1 55 axitinib 55 TIED FOR 55 MY BEST 55 Xelox 55 WILL GRADUALLY 55 IT WAS JUST 55 YOU WOULD CHANGE 55 TO SUCCESS 55 VICTORY FOR 55 LITTLE MISS 55 CARDS AND 55 ORENCIA ® 55 FEAR FOR 55 huN# DM1 55 REALTY INCOME 55 Arimidex Tamoxifen Alone 55 Commences Phase 55 Quinamed 55 MAY BE DEEMED TO 55 EVEREST II 55 FIRST QUARTER FINANCIAL RESULTS 55 ADDITIONALLY 55 REPEATS 55 JUSTICE AND 55 ARBITER 6 55 CHEAP ONLINE PHARMACY BEST 55 PLACE YOUR 55 AGREEMENT FOR 55 BY SALLY 55 THIS STATEMENT 55 XIENCE TM 55 AND SERVE 55 Ranolazine 55 LIVING ROOM 55 SEASONS OF 55 FOR FAILING 55 AND GIRLS 55 SEAMLESS 55 vidofludimus 55 SEIZES 55 BOW TO 55 X# HER SISTER 55 Antiviral Activity 55 CD# [004] 55 generation purine nucleoside 55 AND RECOMMENDATIONS 55 RUNNING ON 55 AN EYE FOR 55 ENDEAVOR IV 55 METHOD FOR 55 CHALLENGE FOR 55 WANTS TO BE 55 evaluating tivozanib 55 ARE OUT OF 55 GOES FOR 55 EVALUATIONS 55 HYPERTENSION 55 FUMES 55 Phase IIB 55 INCOMPLETE 55 CARRIES ON 55 oral Xeloda 55 STAY IN THE 55 CD3 monoclonal antibody 55 evaluating carfilzomib 55 liposomal formulation 55 THE IMPLEMENTATION OF 55 SEACOAST 54 USE YOUR 54 PIVOTAL 54 HAYE 54 AIMING FOR 54 brivaracetam 54 COMPETITION FOR 54 'S ULTIMATE 54 ORATORIO 54 HDAC Inhibitor 54 EXPERIMENT 54 OR REVOKED LICENSE 54 OF EXCELLENCE 54 AND CONDITIONS 54 LISTEN FOR 54 GIVER 54 LEFTWICH 54 WORKS FOR 54 WE 'RE STILL 54 Ophena TM 54 GATHERS 54 Phase IIa trial 54 IN PEACE 54 LOST HIS 54 TISSUE 54 INCENTIVES FOR 54 Confirmatory Phase 54 Phase Ib 54 TRAINING PROGRAMME 54 WISHING HIM 54 randomized discontinuation trial 54 HAND OVER 54 YOUR LOCAL ANIMAL SHELTER 54 trastuzumab DM1 T DM1 54 CELESTIAL 54 DATE WITH 54 THAT ARE DIFFICULT TO 54 AMCG DEST FISH HUDV 54 SUGGEST THAT 54 TREATMENT OPTIONS 54 CUT DOWN 54 COMPARE 54 QUESTIONS ABOUT 54 THING YOU 54 alfa 2a 54 BEGINS TODAY 54 MAY PRODUCE 54 TOSELAND 54 PGAL SHOW 54 INCLUDING CONTACT DETAILS 54 XIENCE V PROMUS Stent 54 MEDTRONIC 54 placebo controlled Phase III 54 WHO GETS 54 ARE LIKELY 54 Phase Ib clinical trials 54 #.T HITS 54 double blinded placebo 54 Truvada tablets 54 bosentan 54 HORIZONS 54 MAY NEED 54 IN MY HEART 54 CHAIN OF 54 HISTORIC WIN 54 SOME MORE 54 GALNS 54 THE DAMAGE 54 CORD II 54 brivanib 54 FOR HER 54 POWER LINE 54 FROM THE OPINIONJOURNAL 54 OR VISIT 54 THERAPIES 54 WEIGHS 54 Acute Ischemic Stroke 54 Combination REOLYSIN R 54 DECISION CONCERNING THE 54 arsenic trioxide injection 54 GRAVITAS trial 54 LAST TWO YEARS 54 REQUEST FOR 54 PRECEDING 54 FOR BREAST CANCER 54 gemcitabine Gemzar ® 54 MATTERS OF 54 LIVING IN THE 54 ONE LAST 54 RECORDATI 54 WORLD WAR 54 Proc Am Soc 54 fidaxomicin Phase 54 YOU WOULD LIKE 54 MORE THAN ONE 54 CELGENE 54 IS EVERYTHING 54 THROW AWAY 54 HIM UP 54 STUCK IN 54 HOW WE 54 STAINED 54 PUBLISHED IN 54 FALL INTO 54 'S DOUBLE 54 EXCEEDS 54 IS NOT TO BE 54 JS ACQUISITION HAS COMMENCED 54 EXCITED ABOUT 54 MOMENTS OF 54 WOMEN WHO 54 VASCULAR 54 LIGHT FREEZING RAIN 54 PREGNANT AGAIN 54 'S STILL 54 SHADES OF 54 SONGWRITING 54 Carotid Revascularization Endarterectomy vs. 54 'S LIFE 54 PROVE IT 54 CITY EDITOR 54 BE PREPARED FOR SLIPPERY 54 DRIVE FOR 54 MATERIALS AND 54 RELATES TO 54 GORDON 'S 54 GET READY FOR 54 TO ANSWER 54 non nucleoside inhibitor 54 ON IMMIGRATION 54 CANDIDATE 'S 54 INTENDS TO 54 FALL FROM 54 CAN NOT STOP 54 multicenter multinational 54 BNA PRIME MINISTER SHAIKH 54 pharmacokinetic PK 54 PAROLE BOARD 54 telaprevir dosed 54 STRAUSS 54 Second Pivotal Phase 54 Phase 2a 54 WANTS MORE 54 Phase 2b Clinical Trial 54 OTHER SIDE OF 54 MOMENT OF 54 bevacizumab Avastin ® 54 LEGG MASON